Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Resmed (RMD)
NYSE:RMD
RMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$170.56 - $263.05
Previous CloseN/A
Volume178.41K
Average Volume (3M)1.00M
Market Cap
$33.86B
Enterprise Value$34.05B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)27.2
Beta1.27
Next Earnings
Apr 24, 2025EPS Estimate
2.38Last Dividend Ex-Date
Feb 13, 2025Dividend Yield0.88%
Share Statistics
EPS (TTM)8.46
Shares Outstanding146,866,910
10 Day Avg. Volume854,796
30 Day Avg. Volume1,002,900
Standard Deviation0.09
R-Squared0.16
Alpha0.00322
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)6.87
Price to Cash Flow (P/CF)27.40
P/FCF Ratio27.40
Enterprise Value/Market Cap1.01
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit12.82
Enterprise Value/Ebitda20.56
Forecast
1Y Price Target
$274.89Price Target Upside18.08% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
---
Bulls Say, Bears Say
Bulls Say
Device GrowthUS Device growth at 12% outpaces the CPAP market growth rate of 5-7%, indicating greater new patient engagement at the PCP level.
Market ShareMarket share gains are evident, partially aided by Philips’ issues.
Bears Say
Pharmaceutical CompetitionFeedback suggests pharmaceuticals may reduce the number of patients on CPAP, rather than expand.
---
Ownership Overview
0.53% Insiders
16.70% Mutual Funds
9.30% Other Institutional Investors
49.80% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
RMD FAQ
What was Resmed’s price range in the past 12 months?
Resmed lowest stock price was $170.56 and its highest was $263.05 in the past 12 months.
What is Resmed’s market cap?
Resmed’s market cap is $33.86B.
When is Resmed’s upcoming earnings report date?
Resmed’s upcoming earnings report date is Apr 24, 2025 which is in 62 days.
How were Resmed’s earnings last quarter?
Resmed released its earnings results on Jan 30, 2025. The company reported $2.43 earnings per share for the quarter, beating the consensus estimate of $2.316 by $0.114.
Is Resmed overvalued?
According to Wall Street analysts Resmed’s price is currently Undervalued.
Does Resmed pay dividends?
Resmed pays a Quarterly dividend of $0.529 which represents an annual dividend yield of 0.88%. See more information on Resmed dividends here
What is Resmed’s EPS estimate?
Resmed’s EPS estimate is 2.38.
How many shares outstanding does Resmed have?
Resmed has 146,866,910 shares outstanding.
What happened to Resmed’s price movement after its last earnings report?
Resmed reported an EPS of $2.43 in its last earnings report, beating expectations of $2.316. Following the earnings report the stock price went down -8.332%.
Which hedge fund is a major shareholder of Resmed?
Currently, no hedge funds are holding shares in RMD
---
Resmed Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$274.89 (18.08% Upside)
$274.89 (18.08% Upside)
Blogger Sentiment
Bullish
RMD Sentiment 87%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 22.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $2.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 2.4%
Last 30 Days ▲ 4.5%
Last 30 Days ▲ 4.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
31.12%
12-Months-Change
Fundamentals
Return on Equity
25.65%
Trailing 12-Months
Asset Growth
3.42%
Trailing 12-Months
Company Description
Resmed
Founded in 1989, California-based ResMed, Inc. is a medical equipment company. The company is engaged in the development, manufacturing, distribution, and marketing of medical equipment and software solutions. The company operates through two segments: Sleep and Respiratory Care, and SaaS (Software as a Service).
---
RMD Company Deck
---
RMD Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a strong financial performance with significant growth in revenue, device sales, and earnings per share. The company highlighted successful product innovations and strategic collaborations. Despite some currency-related revenue impacts and potential tariff concerns, the overall sentiment remains positive with a focus on sustained growth and innovation.Read More>---
RMD Revenue Breakdown
87.53% Sleep and Respiratory Care
12.47% Software as a Service
---
RMD Stock 12 Month Forecast
Average Price Target
$274.89
▲(18.08% Upside)
Technical Analysis
Baxter International
―
Becton Dickinson
―
Koninklijke Philips
―
Medtronic
―
Thermo Fisher
―
Best Analysts Covering RMD
1 Year
1 Year Success Rate
13/20 ratings generated profit
1 Year Average Return
+4.84%
reiterated a buy rating 22 days ago
Copying David Low's trades and holding each position for 1 Year would result in 65.00% of your transactions generating a profit, with an average return of +4.84% per trade.
---